A latest report denoted that tumor necrosis factor receptor-associated factor (TRAF) family member-associated NF-κB activator (TANK)-binding kinase 1 (TBK1) acted as a mediator of platelet-induced NF-κB activation and EMT in mammary carcinoma cells (157). This evidence concerns the gene TBK1 and breast carcinoma.